Pages that link to "Q53575519"
Jump to navigation
Jump to search
The following pages link to Costimulatory molecule-targeted immunotherapy of cutaneous graft-versus-host disease. (Q53575519):
Displaying 16 items.
- Roles of Host Nonhematopoietic Cells in Autoimmunity and Donor Cell Engraftment in Graft-versus-host Disease (Q33896432) (← links)
- Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation (Q35657838) (← links)
- Anti-CD137 mAb Deletes Both Donor CD4+and CD8+T Cells in Acute Graft-versus-host Disease (Q35745542) (← links)
- MHC-compatible bone marrow stromal/stem cells trigger fibrosis by activating host T cells in a scleroderma mouse model. (Q36539693) (← links)
- Immune regulation and control of regulatory T cells by OX40 and 4-1BB (Q36794126) (← links)
- Hypercostimulation through 4-1BB distorts homeostasis of immune cells (Q37267938) (← links)
- Biology of chronic graft-versus-host disease: implications for a future therapeutic approach (Q37294468) (← links)
- Intervention with costimulatory pathways as a therapeutic approach for graft-versus-host disease (Q37785736) (← links)
- More than skin deep? Emerging therapies for chronic cutaneous GVHD. (Q38032083) (← links)
- Regulation of myelopoiesis by CD137L signaling. (Q38221212) (← links)
- Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth. (Q38417709) (← links)
- CD137-CD137 Ligand Interactions in Inflammation (Q42042753) (← links)
- Effects of Pravastatin on Murine Chronic Graft-Versus-Host Disease (Q42920928) (← links)
- Fluctuations in pathogenic CD4+ T-cell subsets in a murine sclerodermatous model of chronic graft-versus-host disease (Q44083370) (← links)
- Host CD25+CD4+Foxp3+ Regulatory T Cells Primed by anti-CD137 mAbs Inhibit Graft-versus-Host Disease (Q50990078) (← links)
- The Costimulatory Pathways and T Regulatory Cells in Ischemia-Reperfusion Injury: A Strong Arm in the Inflammatory Response? (Q55162275) (← links)